Related Experiment Videos

[Percutaneous valvulotomy for calcified aortic valve stenosis in the adult]

F Fernández Vázquez1, M A Martínez Ríos, M Gil Moreno

  • 1Instituto Nacional de Cardiologia, Ignacio Chávez, México, D.F.

Archivos Del Instituto De Cardiologia De Mexico
|July 1, 1989
PubMed

Insights

Percutaneous aortic balloon valvuloplasty offers promising results for adult aortic valve stenosis patients not eligible for surgery. This initial study showed an 80% success rate with no mortality, indicating a viable treatment option.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Calcified aortic valve stenosis is a significant cause of morbidity and mortality in adults.
  • Surgical aortic valve replacement is the standard treatment, but many patients are poor surgical candidates.
  • Percutaneous aortic balloon valvuloplasty (PABV) is an alternative therapeutic option.

Observation:

  • This study reports the initial experience with PABV at the Instituto Nacional de Cardiología "Ignacio Chávez".
  • Five adult patients (4 males, 1 female, mean age 54 years) with calcified aortic valve stenosis were included.
  • All patients had poor ventricular function and were deemed inoperable.

Findings:

  • The study achieved an 80% success rate in PABV.
  • No mortality was observed in the patient cohort.
  • In one case, the transvalvular gradient could not be modified, indicating a limitation.

Implications:

  • PABV demonstrates promising outcomes for inoperable patients with aortic valve stenosis.
  • This minimally invasive procedure offers a potential alternative to surgery with a favorable safety profile.
  • Further research with larger cohorts is warranted to confirm these findings and optimize PABV techniques.

Related Concept Videos